The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Quest Diagnostics Inc

NYSE: DGX
Last

(U.S.) $73.81

Today's change+0.32 +0.44%
Updated July 31 4:04 PM EDT. Delayed by at least 15 minutes.
 

Quest Diagnostics Inc

NYSE: DGX
Last

(U.S.) $73.81

Today's change+0.32 +0.44%
Updated July 31 4:04 PM EDT. Delayed by at least 15 minutes.

Quest Diagnostics Inc up (U.S.)$0.32

Quest Diagnostics Inc closed up Friday by (U.S.)$0.32 or 0.44% to (U.S.)$73.81. Over the last five days, shares have gained 0.60% and 10.07% year to date. Shares have outperformed the S&P 500 by 11.83% during the last year.

Key company metrics

  • Open(U.S.) $73.74
  • Previous close(U.S.) $73.49
  • High(U.S.) $74.49
  • Low(U.S.) $73.65
  • Bid / Ask-- / --
  • YTD % change+10.07%
  • Volume1,099,074
  • Average volume (10-day)1,112,553
  • Average volume (1-month)1,067,605
  • Average volume (3-month)1,449,352
  • 52-week range(U.S.) $56.27 to (U.S.) $89.00
  • Beta0.67
  • Trailing P/E21.94×
  • P/E 1 year forward15.50×
  • Forward PEG1.82×
  • Indicated annual dividend(U.S.) $1.52
  • Dividend yield2.06%
  • Trailing EPS(U.S.) $3.36
Updated July 31 4:04 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+7.06%

Based on its net profit margin of 7.06%, Quest Diagnostics Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.60%Sector:HealthcareIndustry:Healthcare Facilities
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2015Q4/2014Q3/2014Q2/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014Jun 30, 201406/30/2014
Revenue1,8391,8831,9041,902
Total other revenue--------
Total revenue1,8391,8831,9041,902
Gross profit689701733732
Total cost of revenue1,1501,1821,1711,170
Total operating expense1,6111,6261,6481,640
Selling / general / administrative417420437434
Research & development--------
Depreciation / amortization21232425
Interest expense (income), net operating--------
Unusual expense (income)159167
Other operating expenses, total8-804
Operating income228257256262
Interest income (expense), net non-operating-45-43-42-42
Gain (loss) on sale of assets--------
Other--------
Income before tax112223221229
Income after tax70195139142
Income tax, total42288287
Net income61190129133
Total adjustments to net income--0-10
Net income before extra. items61185129133
Minority interest-9-10-10-9
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items61185128133
Inc. avail. to common incl. extra. items61190128133
Diluted net income61190128133
Dilution adjustment--------
Diluted weighted average shares146148145145
Diluted EPS excluding extraordinary itemsvalue per share0.421.250.880.92
Dividends per sharevalue per share0.330.330.330.33
Diluted normalized EPSvalue per share0.481.300.950.95